Hannah Fry

Insider Reports History

Location
New York, NY
Signature
/s/ Hannah Fry
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Hannah Fry:

Company Role Class Num Shares Value Price $ Report Date Ownership
Protara Therapeutics, Inc. VP, Controller Common Stock 42,723 $284,962 $6.67 26 Jan 2026 Direct
Protara Therapeutics, Inc. VP, Controller Stock Option (Right to Buy) 55,000 16 Jan 2026 Direct

Insider Reports Filed by Hannah Fry

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TARA Protara Therapeutics, Inc. 26 Jan 2026 1 -$9,718 4 VP, Controller 27 Jan 2026, 16:10
TARA Protara Therapeutics, Inc. 20 Jan 2026 1 -$11,939 4 VP, Controller 22 Jan 2026, 16:30
TARA Protara Therapeutics, Inc. 16 Jan 2026 2 $0 4 VP, Controller 21 Jan 2026, 16:36
TARA Protara Therapeutics, Inc. 24 Jan 2025 0 $0 4/A VP, Controller 28 Mar 2025, 16:05
TARA Protara Therapeutics, Inc. 21 Jan 2025 1 -$10,139 4 VP, Controller 23 Jan 2025, 16:05
TARA Protara Therapeutics, Inc. 03 Jan 2025 1 -$2,419 4 VP, Controller 07 Jan 2025, 16:20
TARA Protara Therapeutics, Inc. 19 Jan 2024 3 -$1,727 4 VP, Controller 23 Jan 2024, 16:05
TARA Protara Therapeutics, Inc. 03 Jan 2024 1 -$703 4 VP, Controller 05 Jan 2024, 16:05
TARA Protara Therapeutics, Inc. 17 Jul 2023 1 -$25,792 4 VP, Controller 18 Jul 2023, 16:05
TARA Protara Therapeutics, Inc. 19 Jan 2023 2 $0 4 VP, Controller 20 Jan 2023, 15:00
TARA Protara Therapeutics, Inc. 03 Jan 2023 1 -$1,011 4 VP, Controller 04 Jan 2023, 15:24
TARA Protara Therapeutics, Inc. 16 Jul 2022 1 $0 4 VP, Controller 19 Jul 2022, 16:06
TARA Protara Therapeutics, Inc. 16 Jul 2022 0 $0 3 VP, Controller 19 Jul 2022, 16:05